Resveratrol—A prostate cancer chemopreventive agent?
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 7 (6) , 223-227
- https://doi.org/10.1016/s1078-1439(02)00194-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- SELECT: THE NEXT PROSTATE CANCER PREVENTION TRIALJournal of Urology, 2001
- Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancerUrology, 2001
- Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasiaUrology, 2001
- The Prostate Cancer Prevention Trial: Current status and lessons learnedUrology, 2001
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Diet and Its Preventive Role in Prostatic DiseaseEuropean Urology, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Family History and Prostate Cancer Risk in Black, White, and Asian Men in the United States and CanadaAmerican Journal of Epidemiology, 1995
- Prostatic intraepithelial neoplasia (PIN): Current conceptsJournal of Cellular Biochemistry, 1992
- International trends in prostatic cancerInternational Journal of Cancer, 1984